Positron Emission Tomography (PET) Predictors of Tumor Response to Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic Neuroendocrine Tumors (NET)

被引：0
|
作者：
Ladwa, R. [1 ]
Pattison, D. [2 ]
Smith, J. [2 ]
Goodman, S. [2 ]
Burge, M. [3 ]
Rose, S. [4 ]
Dowson, N. [4 ]
Wyld, D. [3 ]
机构：
[1] Univ Queensland, Sch Med, Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Nucl Med & Specialised PET Serv, Brisbane, Qld, Australia
[3] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Canc Care Serv, Brisbane, Qld, Australia
[4] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
68ga-dotatate pet-ct; suv parameters; tumor response; somatostatin receptor tumor volume;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K11
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [31] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS: THE UNIVERSITY GENERAL HOSPITAL OF ATHENS "ATTIKON" PARADIGM
    Liotsou, T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6031 - 6031
  • [32] Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
    Foster, Jennifer H.
    Sher, Andrew
    Seghers, Victor
    Poston, Jay
    Wells, Donald
    Delpassand, Ebrahim S.
    Potter, Samara
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [33] Quality of life assessment following peptide receptor radionuclide therapy (PRRT) of pancreatic neuroendocrine tumor (P-NET)
    Marinova, Milka
    Muecke, Martin
    Mahlberg, Lukas
    Essler, Markus
    Cuhls, Henning
    Radbruch, Lukas
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [34] Chromogranin A (CgA) and Pancreastatin (PcSt) as Predictors of Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in Patients with Metastatic Well-Differentiated Neuroendocrine Tumors (mNETs)
    Sharma, N.
    Naraev, B.
    Engelman, E.
    Zimmerman, M. B.
    Bushnell, D.
    O'Dorisio, T.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2012, 96 : 59 - 59
  • [35] Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation
    Savelli, Giordano
    Zaniboni, Alberto
    Bertagna, Francesco
    Bosio, Giovanni
    Nisa, Lutfun
    Rodella, Carlo
    Biasiotto, Giorgio
    Bettinsoli, Giovanni
    Migliorati, Elena
    Peli, Alessia
    Falchi, Roberta
    Giuffrida, Francesca
    Giubbini, Raffaele
    BREAST CARE, 2012, 7 (05) : 408 - 410
  • [36] Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
    Camus, Baptiste
    Cottereau, Anne-Segolene
    Palmieri, Lola-Jade
    Dermine, Solene
    Tenenbaum, Florence
    Brezault, Catherine
    Coriat, Romain
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 18
  • [37] The value of dosimetry in Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumors: literature and practical aspects
    Di Dia, Amalia
    Ferrari, Mahila E.
    Travaini, Laura Lavinia
    Grappeja, Lorenza
    Guglielmo, Priscilla
    Barone, Antonio
    Mei, Riccardo
    Papi, Stefano
    Ceci, Francesco
    Grana, Chiara Maria
    CLINICAL AND TRANSLATIONAL IMAGING, 2025, : 121 - 129
  • [38] Utility of midpoint imaging in patients receiving peptide receptor radionuclide therapy (PRRT) for advanced progressive midgut neuroendocrine tumors (NET)
    Norman, A.
    Wee, C.
    Hobday, T.
    Kendi, A.
    Johnson, G.
    Thorpe, M.
    Lunn, B.
    Bach, C.
    Eiring, R.
    Halfdanarson, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 192 - 192
  • [39] Peptide receptor radionuclide therapy of neuroendocrine tumors
    Haug, A. R.
    Bartenstein, P.
    ONKOLOGE, 2011, 17 (07): : 602 - +
  • [40] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Bodei, Lisa
    Kidd, Mark
    Prasad, Vikas
    Modlin, Irvin M.
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 198 - 215
12345